ArticleProteomics2015

Silencing of high-mobility group box 2 (HMGB2) modulates cisplatin and 5-fluorouracil sensitivity in head and neck squamous cell carcinoma.

Nazia Syed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.